Menu
Recruiting NCT07192887

Thebaine Urine Testing

Observational Urine Specimen Collection

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Urine Specimen Collection. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Clinical Feasibility of Thebaine Urine Mass Spectrometry Drug Testing

Overview

To develop and validate a urine drug screen to detect thebaine.

Primary outcome measures

  • Validate thebaine urine screen [Time frame: Enrollment to 48 hours after enrollment]

Eligibility criteria

Inclusion criteria

  • Male or female
  • Ages 18-65
  • Healthy

Exclusion criteria

  • Allergy to poppy seeds, or any of the related food stuffs used in the study
  • Celiac disease or gluten sensitivity
  • Ongoing or opioid use in the past 6 months
  • History of renal or hepatic disease or dysfunction
  • Inability or unwillingness to give repeated urine specimens
  • Unwillingness to refrain from eating poppy seed-containing products during the two-day course of the study
  • Non-English speakers (due to study materials being in English)
  • BMI greater than 30
  • Antibiotic use in the previous 2 months
  • Recent ingestion of poppy seeds from the previous 7 days

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

United States · 1 center
  • Cincinnati Children's Hospital Medical Center — Cincinnati

Identifiers

NCT: NCT07192887 · 2024-0818

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗